Literature DB >> 29769973

Regulatory oversight of human pathogens and toxins in Canada.

C Labrie1, S Lecordier1.   

Abstract

From 1994 to 2009, federal oversight of human pathogens and toxins was limited to facilities importing human pathogens and toxins into Canada under the Human Pathogens Importation Regulations (HPIR). This narrow focus of authority restricted the Government of Canada's ability to regulate and monitor a full range of activities, including those involving human pathogens and toxins acquired from domestic sources. In 2009, the Human Pathogens and Toxins Act (the Act) received Royal Assent to establish a national safety and security regime and expand oversight through a national, standardized process to verify safe and secure use of human pathogens and toxins in Canada. The Act and the Human Pathogens and Toxins Regulations (the Regulations), in full force since December 1, 2015, provides legislative and statutory requirements for the comprehensive oversight of the control of human pathogens and toxins in Canada. Expanded regulation and monitoring program activities aim to reduce the risks posed by human pathogens and toxins and strengthen biosafety management systems that serve to protect the health of Canadians.

Entities:  

Year:  2015        PMID: 29769973      PMCID: PMC5868715          DOI: 10.14745/ccdr.v41is6a03

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  2 in total

1.  Federal public health strategies to minimize the importation of communicable diseases into Canada.

Authors:  N Bhatia; S Sarwal; H Robinson; J Geduld; F Huneault; H Schreiner; S Collins; R Hickey
Journal:  Can Commun Dis Rep       Date:  2015-12-17

2.  Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.

Authors:  A Bienek; M Heisz; M Su
Journal:  Can Commun Dis Rep       Date:  2017-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.